Epidiolex Counterpart Debuts In Brazil’s Cannabis Market As Its Maker Eyes TSX IPO

 Epidiolex Counterpart Debuts In Brazil’s Cannabis Market As Its Maker Eyes TSX IPO

Verdemed, a pharmaceutical company known for producing cannabis-derived products, has received five fresh approvals from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitár…